机构

• 上海药物研究所 [9]
• 自动化研究所 [1]

采集方式

• OAI收割 [10]

内容类型

• 期刊论文 [10]

发表日期

• 2024 [1]
• 2023 [3]
• 2022 [3]
• 2021 [2]
• 2019 [1]

学科主题

筛选

浏览/检索结果: 共10条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Excessive fatty acids activate PRMT5/MDM2/Drosha pathway to regulate miRNA biogenesis and lipid metabolism 期刊论文  OAI收割 LIVER INTERNATIONAL, 2024, 页码: 17 作者:  Hou, Aijun;  Xu, Xiaoding;  Zhang, Yu;  He, Hongxiu;  Feng, Yihan   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/05/07 Drosha degradation  lipid metabolism  miRNA biogenesis  NAFLD  PRMT5   MiR-337-3p improves metabolic-associated fatty liver disease through regulation of metabolism 期刊论文  OAI收割 ISCIENCE, 2023, 卷号: 26, 期号: 11, 页码: 18 作者:  Xu, Xiaoding;  Yu, Chuwei;  He, Hongxiu;  Pan, Xiangyu;  Hou, Aijun   |  收藏  |  浏览/下载：41/0  |  提交时间：2024/01/16 Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers 期刊论文  OAI收割 MOLECULAR CANCER THERAPEUTICS, 2023, 卷号: 22, 期号: 8, 页码: 913-925 作者:  Zhou, Wei;  Fang, Peng;  Yu, Dongan;  Ren, Hongyuan;  You, Meng   |  收藏  |  浏览/下载：26/0  |  提交时间：2023/10/17 MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 卷号: 19, 期号: 11, 页码: 3456-3471 作者:  Ma, Ningning;  Hou, Aijun;  Pan, Xiangyu;  Sun, Fuguang;  Xu, Xiaoding   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/10/17 MiR-552-3p  NASH  Fibrosis  Inflammation  Synergistic multi-target suppression   HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis 期刊论文  OAI收割 MOLECULAR CANCER RESEARCH, 2022, 卷号: 20, 期号: 12, 页码: 1724-1738 作者:  Mou, Jiahui;  Huang, Meijun;  Wang, Feifei;  Xu, Xiaoding;  Xie, Hanqi   |  收藏  |  浏览/下载：25/0  |  提交时间：2023/04/10 MicroRNA-379-5p regulates free cholesterol accumulation and relieves diet induced-liver damage in db/db mice via STAT1/HMGCS1 axis 期刊论文  OAI收割 Molecular biomedicine, 2022, 卷号: 3, 期号: 1, 页码: 25 作者:  Dong, Yunxia;  Yu, Chuwei;  Ma, Ningning;  Xu, Xiaoding;  Wu, Qian   |  收藏  |  浏览/下载：42/0  |  提交时间：2024/03/15 Cholesterol metabolism  HMGCS1  MiR-379-5p  Non-alcoholic fatty liver disease  STAT1   HMGN4 plays a key role in STAT3-mediated oncogenesis of triple-negative breast cancer 期刊论文  OAI收割 CARCINOGENESIS, 2022, 页码: 11 作者:  Mou, Jiahui;  Xu, Xiaoding;  Wang, Feifei;  Kong, Weiwen;  Chen, Jing   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/09/30 MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice 期刊论文  OAI收割 METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 卷号: 119, 页码: 12 作者:  Xu, Xiaoding;  Dong, Yunxia;  Ma, Ningning;  Kong, Weiwen;  Yu, Chuwei   |  收藏  |  浏览/下载：40/0  |  提交时间：2021/08/17 miR-337-3p  PCSK9  LDL-C  Hyperlipidemia  Dual regulation   New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice 期刊论文  OAI收割 PHARMACOLOGICAL RESEARCH, 2021, 卷号: 167, 页码: 13 作者:  Ma, Ningning;  Fan, Lei;  Dong, Yunxia;  Xu, Xiaoding;  Yu, Chuwei   |  收藏  |  浏览/下载：56/0  |  提交时间：2021/08/17 PCSK9  Hyperlipidemia  MiR-552-3p  3 '-UTR  Promoter   Dynamic Liquid Surface Enhanced Raman Scattering Platform Based on Soft Tubular Microfluidics for Label-Free Cell Detection 期刊论文  OAI收割 ANALYTICAL CHEMISTRY, 2019, 卷号: 91, 期号: 13, 页码: 7973-7979 作者:  Xu, Xiaoding;  Zhao, Lei;  Xue, Qilu;  Fan, Jinkun;  Hu, Qingqing   |  收藏  |  浏览/下载：72/0  |  提交时间：2019/12/16